Jump to content
RemedySpot.com

Re: Mifepristone

Rate this topic


Guest guest

Recommended Posts

In a message dated 00-11-06 23:35:47 EST, you write:

<< I really wonder if the fibroid shrinking benefit of this synthetic...I

assume it is a synthetic hormone...is due to the fact that it makes the

uterus EXPEL...how does it do this? Does it create contractions? If

so, it could affect the blood supply to fibroids...does anyone know

" WHY " the drug companies are saying this works? S >>

I don't know the " why " but it's not the drug companies saying it works. There

have been studies at the University of California (San Diego) in 1993 and the

University of Rochester in 2000 that have established that the drug, which

suppresses progesterone in the body, does indeed cause the fibroids to

shrink. From what I've read and been told, it inhibits ovulation and stops a

woman's periods; the only other side effects that have been mentioned are

mild hot flashes and sometimes headaches. No contractions, no " expelling "

from the uterus. The dosage in the trials was very small (25 mg, as opposed

to the 600 mg used for abortions); once a woman stops taking it, her system

returns to normal.

Link to comment
Share on other sites

> In a message dated 00-11-06 23:35:47 EST, you write:

>

> << I really wonder if the fibroid shrinking benefit of this

>synthetic...I assume it is a synthetic hormone...is due to the fact

>that it makes the uterus EXPEL...how does it do this? Does it create

>contractions?

***As I understand it, mifepristone does not make the uterus

expel or contract, even in doses given for abortions. Another drug has

to be given in order to make the uterus contract. The mifepristone

obviously affects the uterine lining and the fibroids without causing

either to be expelled. It obviously works, according to several

studies done in university medical settings.

dana

Link to comment
Share on other sites

  • 2 months later...

Hi Carla,

THIS is exactly what needs to happen. If enough of us will speak up

something might change. Attached is the complete list of Inclusion &

Exclusion criteria. I have copied this from an Excel spreadsheet - hope it

is legible.

INCLUSION CRITERIA:

1. Pre-menopausal and 18 years of age or older

2. Active symptoms of myomata and have a total myomatous or

uterine size greater than or equal to 300 cc (myomatous volume

defined by the sum of each myoma volume)

3. Meet ACOG guidelines for hysterectomy or myomectomy

4. Authorization of Release of Information by Primary care provider

5. Good general and mental health

6. Agree to abstain from sex or use non-hormonal contraception

to prevent pregnancy

EXCLUSION CRITERIA:

1. Pregnant or desire to become pregnant

2. Breast feeding

3. Adnexal masses or adnexal tenderness indicating further

evaluation or surgery

4. Any of the following:

Sickle cell anemia

Adrenal disease

Liver disease (severe)

Respiratory disease (severe)

Blood clotting defect

5. Exclusion medications

Steroid medications

Anticoagulants- such as Coumadin

Hormones- such as estrogen, androgen, oral contraceptives

or progestins forthree months, except Depo-provera.

No use for six months of GnRH analogs,Danazol, and Depo-provera

No use of herbal/botanical supplements with possible hormonal effects

Herbal Supplements with Possible

Female Hormonal Effects

Dong quai ( sinensis)

Black cohosh (Cimicifuga racemosa)

Blue cohosh (Caulophyllum thalictroides)

Chasteberry (Vitex agnus-castus)

Licorice (Glycyrrhiza blabra)

Life root (Senecio aureus or Senecio nemorensis)

False unicorn root (Veratrum luteum)

Saw palmetto (Serenoa repens)

Soy isoflavones (phytoestrogens)

Genistein

Diadzein

Glycetein

ACOG Criteria for Myomectomy

Procedure: Myomectomy Yes No

Indication: Leiomyomata in infertility patients, as a probable factor

in failure to conceive or in recurrent pregnancy loss

1. Presence of leiomyomata of sufficient size and specific

location to be a probable factor

ACOG Criteria for Hysterectomy for Leiomyomata

Procedure: Hysterectomy, abdominal or vaginalYes No

Indication: Leiomyomata

Confirmation of Indication: Presence of 1 or 2 or 3

1. Asymptomatic leiomyomata of such size that they are

palpable abdominally and are a concern to the patient

2. Excessive uterine bleeding evidenced by either the following:

a) Profuse bleeding with flooding or clots or repetitive periods

lasting for more than 8 days

B) Anemia due to acute or chronic blood loss

3. Pelvic discomfort caused by myomata (a or b or c)

a) Acute and severe

B) Chronic lower abdominal or low back pressure

c) Bladder pressure with urinary frequency not due to urinary

tract infection

Heleen

Project Manager /Clinical Research Coordinator

University of Rochester Medical Center

1000 South Avenue

Rochester, New York

14620

Telephone:

Fax

E-mail Heleen_leroux@...

mifepristone

The major group to look to for information on how to become an activist re:

RU-486 research is the Feminist Majority Foundation. They have been

administering the compassionate use program for RU-486 in the U.S. and have

been the organization footing the bill and doing all the work getting this

drug approved.

http://www.feminist.org <http://www.feminist.org>

I would strongly urge you to forward your email to them (as well as your

Congressional reps) so that your voice can be heard in Congress on this

issue.

Also, if you are interested in visiting Washington, D.C. in June to speak

with your Congressional reps on this issue as well as others related to

fibroid research, please email me offline.

As for the study that you were unable to get into, could one of the

researchers involved in RU-486 trials patient enrollment please identify

more clearly any exclusionary factors for becoming a participant in a study

to this list group so more women don't encounter a similar frustration with

hanging their hat on getting into a study when it just may not be possible?

Carla Dionne

Executive Director

National Uterine Fibroids Foundation

mailto:carla@...

http://www.NUFF.org <http://www.NUFF.org>

/list/uterinefibroids

</list/uterinefibroids>

Personal email & website:

mailto:cdionne@...

http://www.uterinefibroids.com <http://www.uterinefibroids.com>

" Never doubt that a small group of thoughtful committed citizens can change

the world. Indeed it's the only thing that ever has. " Margaret Mead

Link to comment
Share on other sites

Hi Carla,

THIS is exactly what needs to happen. If enough of us will speak up

something might change. Attached is the complete list of Inclusion &

Exclusion criteria. I have copied this from an Excel spreadsheet - hope it

is legible.

INCLUSION CRITERIA:

1. Pre-menopausal and 18 years of age or older

2. Active symptoms of myomata and have a total myomatous or

uterine size greater than or equal to 300 cc (myomatous volume

defined by the sum of each myoma volume)

3. Meet ACOG guidelines for hysterectomy or myomectomy

4. Authorization of Release of Information by Primary care provider

5. Good general and mental health

6. Agree to abstain from sex or use non-hormonal contraception

to prevent pregnancy

EXCLUSION CRITERIA:

1. Pregnant or desire to become pregnant

2. Breast feeding

3. Adnexal masses or adnexal tenderness indicating further

evaluation or surgery

4. Any of the following:

Sickle cell anemia

Adrenal disease

Liver disease (severe)

Respiratory disease (severe)

Blood clotting defect

5. Exclusion medications

Steroid medications

Anticoagulants- such as Coumadin

Hormones- such as estrogen, androgen, oral contraceptives

or progestins forthree months, except Depo-provera.

No use for six months of GnRH analogs,Danazol, and Depo-provera

No use of herbal/botanical supplements with possible hormonal effects

Herbal Supplements with Possible

Female Hormonal Effects

Dong quai ( sinensis)

Black cohosh (Cimicifuga racemosa)

Blue cohosh (Caulophyllum thalictroides)

Chasteberry (Vitex agnus-castus)

Licorice (Glycyrrhiza blabra)

Life root (Senecio aureus or Senecio nemorensis)

False unicorn root (Veratrum luteum)

Saw palmetto (Serenoa repens)

Soy isoflavones (phytoestrogens)

Genistein

Diadzein

Glycetein

ACOG Criteria for Myomectomy

Procedure: Myomectomy Yes No

Indication: Leiomyomata in infertility patients, as a probable factor

in failure to conceive or in recurrent pregnancy loss

1. Presence of leiomyomata of sufficient size and specific

location to be a probable factor

ACOG Criteria for Hysterectomy for Leiomyomata

Procedure: Hysterectomy, abdominal or vaginalYes No

Indication: Leiomyomata

Confirmation of Indication: Presence of 1 or 2 or 3

1. Asymptomatic leiomyomata of such size that they are

palpable abdominally and are a concern to the patient

2. Excessive uterine bleeding evidenced by either the following:

a) Profuse bleeding with flooding or clots or repetitive periods

lasting for more than 8 days

B) Anemia due to acute or chronic blood loss

3. Pelvic discomfort caused by myomata (a or b or c)

a) Acute and severe

B) Chronic lower abdominal or low back pressure

c) Bladder pressure with urinary frequency not due to urinary

tract infection

Heleen

Project Manager /Clinical Research Coordinator

University of Rochester Medical Center

1000 South Avenue

Rochester, New York

14620

Telephone:

Fax

E-mail Heleen_leroux@...

mifepristone

The major group to look to for information on how to become an activist re:

RU-486 research is the Feminist Majority Foundation. They have been

administering the compassionate use program for RU-486 in the U.S. and have

been the organization footing the bill and doing all the work getting this

drug approved.

http://www.feminist.org <http://www.feminist.org>

I would strongly urge you to forward your email to them (as well as your

Congressional reps) so that your voice can be heard in Congress on this

issue.

Also, if you are interested in visiting Washington, D.C. in June to speak

with your Congressional reps on this issue as well as others related to

fibroid research, please email me offline.

As for the study that you were unable to get into, could one of the

researchers involved in RU-486 trials patient enrollment please identify

more clearly any exclusionary factors for becoming a participant in a study

to this list group so more women don't encounter a similar frustration with

hanging their hat on getting into a study when it just may not be possible?

Carla Dionne

Executive Director

National Uterine Fibroids Foundation

mailto:carla@...

http://www.NUFF.org <http://www.NUFF.org>

/list/uterinefibroids

</list/uterinefibroids>

Personal email & website:

mailto:cdionne@...

http://www.uterinefibroids.com <http://www.uterinefibroids.com>

" Never doubt that a small group of thoughtful committed citizens can change

the world. Indeed it's the only thing that ever has. " Margaret Mead

Link to comment
Share on other sites

Thanks Heleen.

I also wanted to make a comment regarding the Right to Life's affirmation that

they've never opposed other uses for mifepristone research. They are perfectly

aware of the prevalence of " off-label " use of drugs and know full well that even

if this drug were approved for other medical purposes (other than for abortion)

that it would then be available to also be used as an abortificant. Although

they indicated that they wouldn't oppose other uses of the drug, the reality is

that they most definitely would lose control of this factor if it were approved

for those other uses and not abortion. Once any drug is available for

physicians to prescribe, there is little control over how or what it is

prescribed for. So make no mistake, they oppose this drug from every angle

possible in terms of making it legally available for physicians to prescribe and

patients to use.

As it stands right now, mifepristone is approved for abortion and, unless this

changes with the current political forces that are in play, it should remain

available for fibroid studies. To ensure positive progress on this front, it is

imperative that members who are concerned begin writing their legislative reps

today. Don't put it off. Do it today.

Carla Dionne

Executive Director

National Uterine Fibroids Foundation

mailto:carla@...

http://www.NUFF.org

/list/uterinefibroids

Personal email & website:

mailto:cdionne@...

http://www.uterinefibroids.com

" Never doubt that a small group of thoughtful committed citizens can change the

world. Indeed it's the only thing that ever has. " Margaret Mead

Link to comment
Share on other sites

Thanks Heleen.

I also wanted to make a comment regarding the Right to Life's affirmation that

they've never opposed other uses for mifepristone research. They are perfectly

aware of the prevalence of " off-label " use of drugs and know full well that even

if this drug were approved for other medical purposes (other than for abortion)

that it would then be available to also be used as an abortificant. Although

they indicated that they wouldn't oppose other uses of the drug, the reality is

that they most definitely would lose control of this factor if it were approved

for those other uses and not abortion. Once any drug is available for

physicians to prescribe, there is little control over how or what it is

prescribed for. So make no mistake, they oppose this drug from every angle

possible in terms of making it legally available for physicians to prescribe and

patients to use.

As it stands right now, mifepristone is approved for abortion and, unless this

changes with the current political forces that are in play, it should remain

available for fibroid studies. To ensure positive progress on this front, it is

imperative that members who are concerned begin writing their legislative reps

today. Don't put it off. Do it today.

Carla Dionne

Executive Director

National Uterine Fibroids Foundation

mailto:carla@...

http://www.NUFF.org

/list/uterinefibroids

Personal email & website:

mailto:cdionne@...

http://www.uterinefibroids.com

" Never doubt that a small group of thoughtful committed citizens can change the

world. Indeed it's the only thing that ever has. " Margaret Mead

Link to comment
Share on other sites

Actually, this is the same issue that is problematic for me with the Women's

Health Initiative study on HRT.

http://www.nhlbi.nih.gov/whi/

My mom was in one of the HRT study groups (WAS - she withdrew herself)

and so I called and asked for a copy of the WHI questionnaire and study

plans. I was truly taken aback by the oversight of researchers on

quite a few issues that would indeed impact study outcome. But I

was more appalled by the questions that were NOT asked of my own mother

regarding her medical history which, in my limited nonmedically trained

opinion, should have precluded her from participation in any HRT trial.

I've heard similar stories from others who were never asked about the

OTC hormones they were taking and certainly not told to refrain from using

them while on the WHI study. Too bad. Awfully big, awfully

expensive study to have such oversights. I do know of women who are

using a version of OTC progesterone who are in the calcium study.

So, how will they know whether it's the calcium or something else that

contributes to the documented outcome if they don't ask appropriate intake

questions? Also, why are researchers underestimating the popular

use of progesterone creams (and other OTC hormones) in the marketplace?

Just curious cause I saw another intake questionnaire just today that was

sent to me to review and comment on and the whole realm of OTC hormones

was missing from the data collection questions on hormone use. Surprised

me cuz this just seems like such a big oversight. Comments?

Thoughts?

carla

"LeRoux, Heleen" wrote:

Good question Elise - I will have to get back

to you about that.

RE: mifepristone

Importance: High

Hi Carla,

THIS is exactly what needs to happen. If enough of us will

speak up

something might change. Attached is the complete list of

Inclusion &

Exclusion criteria. I have copied this from an Excel spreadsheet

- hope it

is legible.

INCLUSION CRITERIA:

1. Pre-menopausal and 18 years of age or older

2. Active symptoms of myomata and have a total myomatous or

uterine size greater than or equal to 300

cc (myomatous volume

defined by the sum of each myoma volume)

3. Meet ACOG guidelines for hysterectomy or myomectomy

4. Authorization of Release of Information by Primary care

provider

5. Good general and mental health

6. Agree to abstain from sex or use non-hormonal contraception

to prevent pregnancy

EXCLUSION CRITERIA:

1. Pregnant or desire to become pregnant

2. Breast feeding

3. Adnexal masses or adnexal tenderness indicating further

evaluation or surgery

4. Any of the following:

Sickle cell anemia

Adrenal disease

Liver disease (severe)

Respiratory disease (severe)

Blood clotting defect

5. Exclusion medications

Steroid medications

Anticoagulants- such as Coumadin

Hormones- such as estrogen, androgen, oral contraceptives

or progestins forthree months, except Depo-provera.

No use for six months of GnRH analogs,Danazol,

and Depo-provera

No use of herbal/botanical supplements with possible

hormonal effects

Herbal Supplements with Possible

Female Hormonal Effects

Dong quai ( sinensis)

Black cohosh (Cimicifuga racemosa)

Blue cohosh (Caulophyllum thalictroides)

Chasteberry (Vitex agnus-castus)

Licorice (Glycyrrhiza blabra)

Life root (Senecio aureus or Senecio nemorensis)

False unicorn root (Veratrum luteum)

Saw palmetto (Serenoa repens)

Soy isoflavones (phytoestrogens)

Genistein

Diadzein

Glycetein

ACOG Criteria for Myomectomy

Procedure: Myomectomy Yes No

Indication: Leiomyomata in infertility patients, as a probable

factor

in failure to conceive or in recurrent pregnancy loss

1. Presence of leiomyomata of sufficient size and specific

location to be a probable factor

ACOG Criteria for Hysterectomy for Leiomyomata

Procedure: Hysterectomy, abdominal or vaginalYes

No

Indication: Leiomyomata

Confirmation of Indication: Presence of 1 or 2 or 3

1. Asymptomatic leiomyomata of such size that they are

palpable abdominally and are a concern to the

patient

2. Excessive uterine bleeding evidenced by either the following:

a) Profuse bleeding with flooding or clots or repetitive

periods

lasting for more than 8 days

B) Anemia due to acute or chronic blood loss

3. Pelvic discomfort caused by myomata (a or b or c)

a) Acute and severe

B) Chronic lower abdominal or low back pressure

c) Bladder pressure with urinary frequency not due

to urinary

tract infection

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...